Pinned Tweet
Replying to @GermanBiotech
Everyone who sees these photos and is reasonably healthy should pause for a moment and be somewhat humbled and grateful. Often in everyday life you forget how relatively well you are doing and get angry about trivial things and do not enjoy the here and now.
$ABVX
It is true that the paper “Induction and Long-term Follow-up With ABX464 for Moderate-to-severe Ulcerative Colitis: Results of a Phase IIa Trial,” Gastroenterology 2021;160:2595–2598, is unreliable and riddled with errors. At the time, this did not reflect well on $ABVX.
/1
NEW: We are short $ABVX Abivax SA - a biotech fraud for the ages. Report now live on our site, along with four scientific abstracts based upon our laboratory experiments. An 11-month investigation, our most intensive research to date.
2
7
2,267
I will read through Scorpion Capital’s presentation with interest; I read the Chinese studies on mir-124 mentioned in the summary years ago, but I’m not aware that a key study had been retracted.
I’m curious to see how sound Scorpion’s arguments are.
/2
$ABVX
6
655
During my routine research in the European patent database, I came across some interesting developments from #Peptidream $PPTDF:
1. A Peptide complex with TrkB-binding activity. Indications: neurodegenerative and neuropsychiatric disorder.
/1
1
1
977
2. A peptide/radiopharmaceutical conjugate that binds to EphA2. Indication: Cancer
This is likely the radiopharmaceutical resulting from the collaboration with RAYZEBIO, whose target has not yet been disclosed in the company's pipeline.
#peptidream $PPTDF
/2
1
2
548
3. A peptide capable of binding to a human transferrin receptor (hTfR) as a carrier across the blood-brain barrier for an attached peptide.
#peptidream $PPTDF
/3
2
391
The U.S. midterms show that the U.S. and the world aren't lost yet. Thank goodness!
#Trump #USElections
4
740
$MGNX
I don't see much to be optimistic about in the Phase 2 LINNET interim results.
Not extensive prior treatment; Gr ≥3 TRAEs 49%, 1 TRAE Gr 5 (death), leading to a decision to halve the dose; and even now (at a high dose), the ORR is mediocre.
ir.macrogenics.com/news-rele…
1
3
973
$BNTX ... That doesn't look good.
A higher rate of interstitial lung disease (“ILD”) was reported in this trial compared to prior trials with trastuzumab pamirtecan ... . Severe and fatal events were reported in a small proportion of patients (Grade 3-5)
biontech.com/int/en/home/med…
Promising interim results from a Phase 1 study of $ZYME's ZW191 in heavily pretreated patients with PROC.
$GMAB's Rinatabart sesutecan did not achieve such good results in earlier studies.
globenewswire.com/de/news-re…
$GILD will acquire an oral IL-23R inhibitor program, including lead asset HCXT-2001 (macrocyclic peptide), from PepStar for $1.275 billion in upfront cash.
This shows once again just how undervalued the Japanese #Peptidream $PPTDF is, given its comprehensive peptide portfolio.
7
1,496
PeptiDream $PPTDF Announces First Patient Dosed in Phase 1 Trial → Radiopharmaceutical Program Targeting Carbonic Anhydrase IX for Kidney Cancer.
Operating performance continues to be at odds with the stock price trend.
contents.xj-storage.jp/xcont…
1,279
I think $ZYME's corporate policy of acting as a financial investor in pharmaceutical sectors outside its core business is pretty harebrained.
ir.zymeworks.com/news-releas…
1
4
1,600
There is currently a lot of buzz surrounding oral peptides as treatments for immune-related diseases. In this context, it is worth noting #Peptidream’s IL-17A-binding peptide, which has yet to attract the attention of international investors.
$PPTDF
patents.google.com/patent/US…
1
3
1,506
Outstanding results from $ZYME's anti-FRα ADC ZW191.
78.6% cORR in FRα-pos platinum-resistant ovarian cancer patients and 47.4% in FRα-neg patients across all (!) dose levels studied.
DCR 100% (85%)
mPFS (all patients) 7.6 months
ir.zymeworks.com/news-releas…
German Biotech retweeted
3/1: "four to five weeks"
3/9: "very soon"
3/16: "won't be long"
3/23: "very good and productive conversations"
3/26: talks to end the war are “going very well"
3/29: "I think we'll make a deal with them, pretty sure"
4/1: “very shortly”
4/6: "They’ve made a proposal, and it’s a significant proposal."
4/8: ""A big day for World Peace!"
5/18: "we’ve had very big discussions with Iran"
5/23: "will be announced shortly."
6/1: "rapid pace"
6/11: "next few days"
#Peptidream $PPTDF has initiated clinical development of its CLDN18.2 radiopeptide conjugate for the treatment of GEA.
contents.xj-storage.jp/xcont…
1
2
1,274
Curium and #PeptiDream $PPTDF announce completion of patient dosing in Clinical Trial of 64Cu-PSMA-I&T for Prostate Cancer.
finance.yahoo.com/sectors/he…
1,027
The stock markets are likely to suffer in the near future from numerous massive IPOs, which will drain a lot of liquidity from the market. Recently, geopolitical risks and inflationary threats have also been overlooked. I will definitely be keeping an eye on the $VIX.
1
5
1,209




